Login to Your Account

With Latest IPO by AcelRx, Prices are Still Falling

By Catherine Shaffer

Monday, February 14, 2011
After floating an initial range of $12 to $14 per share, AcelRx Pharmaceuticals Inc. priced its initial public offering (IPO) at $5. The move is consistent with IPOs by other companies in the industry, which are finding that more shares at a lower price is the way to attract buyers in a post-2008 economy.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription